While there is clear recognition of commonly experienced symptoms during the menopause transition, it occurs during a time ...

“Zohran Derangement Syndrome (ZDS) is starting to negatively polarize me into supporting him whereas I’d been relatively ...

ACADIA’s $1B+ 2025 revenue outlook is driven by NUPLAZID and DAYBUE, with ACP-101 offering optional upside despite risks.

Dr Manglani highlights the importance of genetic research in bone cancer, noting early screening and awareness of symptoms ...

Kiniksa expects its current operating plan to remain cash flow positive on an annual basis. Kiniksa will host a conference call and webcast at 8:30 a.m. Eastern Time on Tuesday, July 29, 2025, to ...

Explore how HMBT testing supports IBS diagnosis and related conditions by identifying overlapping symptoms and underlying ...

A quarter of pregnant women have restless leg syndrome, and a fifth of those qualify for medication to treat their sleep disorder.

Ionis Pharmaceuticals Inc (IONS) reports robust revenue growth and strategic advancements, setting the stage for future ...

Q2 2025 net product revenue of $156.8 million, representing 52% year-over-year growth -- ARCALYST 2025 expected net product revenue increased to $625 - $640 million -- KPL-387 ...

HUNDREDS of budding footballers gathered in Glasgow over the weekend in a ‘landmark day for women’s sport’. More than 200 ...

Proof-of-concept studies ongoing in lupus nephritis (LN), systemic sclerosis (SSc) and antibody mediated rejection (AMR); topline results expected for LN in fourth quarter of 2025, SSc in second half ...

The ICU environment itself is inherently stressful, both for patients and their families. Patients are often critically ill, ...